There is only one other company in the U.S., Beeologics, LLC, that is specifically focused on the bee healthcare industry. Beeologics, LLC has recently been acquired by Monsanto Company, a global provider of agricultural products.
Chk out this up & coming freight logistics company – they are expecting $25 million in new contracts this year:
OVERLAND PARK, KS -(Marketwire - 03/14/11) – myFreightWorld Technologies Inc. (MYFT) announced today that it expects its managed revenue business to increase by approximately $25 Million based on recent contract additions. The Company projects total managed revenues for 2011 at $60 Million.
The Company said that it expects the largest percentage of this growth to come from its fee-based, "non contract" business. MYFT CEO J. Michael Head commented, "Within the 3PL industry, very few companies offer what we do, a means to significantly scale up your 3PL transportation business without incurring the costs. With customers like Schneider National and other top-tier Fortune 500 clients, we are successfully implementing a business model that creates much higher profit margins and can save our customers thousands of dollars in software installs and maintenance fees."
MYFT provides transportation solutions to over 100 private labels and serves 8 of the top 50 largest 3PLs (third-party logistics managers) in North America. Contract awards include a previously announced vendor agreement with Schneider National, a global leader in truckload, logistics, and intermodal services.
The writer offers a goal to watch out for: "...With GenVec, I'd say the odds of upside are more like 35/65 (for/against). The payoff, however, could be as much as 4:1 (in my head), provided you don't hang onto a loser for too long. Personally, my cut-bait point for any long trade I had on GNVC would be the $0.63 area, where we saw support in imid-2009. Our upside, however, could be a move to close the gap between here and $2.81. A long shot? Yep. No guts, no glory..."
The writer sets a mark to look for: "...So, if you're stoked about all the news the company has posted over the last eight weeks, I get that. I can't say NexMed, Inc. is an actual 'buy', however, until the $0.55 hurdle is cleared. Conversely, a move under the floor at $0.42 is still a 'sell'. It stinks, to be sure, but this is one of those cases where a small cap stock's price is arbitrarily (and only) defined by opinion, and the opinion is always changing. There is no 'investing' in NEXM... there is only 'trading'. Follow the chart..."
Interesting perspective - from the article: "...If Microvision, Inc. shares do manage to work their way past $3.27, there's a minor problem at $3.64, but a move to the high $5 area isn't out of the question. The only question here is one of pace. If MVSN can simply walk higher without inciting a buying blizzard, it should hit and surpass these milestones within a few weeks. Subtle and sustainable moves have not been this small cap stock's strong aspects though..... be careful of stepping in after a big jump..."